Management of Recurrent Retroperitoneal Sarcoma.
Joshua S JolissaintChandrajit P RautMark FairweatherPublished in: Current oncology (Toronto, Ont.) (2023)
Recurrence after resection of retroperitoneal sarcoma is common and varies by histological subtype. Pattern of recurrence is similarly affected by histology (e.g., well-differentiated liposarcoma is more likely to recur locoregionally, whereas leiomyosarcoma is more likely to develop distant metastases). Radiotherapy may provide effective locoregional control in limited circumstances and the data on the impact of chemotherapy are scant. Surgery for locally recurrent disease is associated with the greatest survival benefit; however, data are retrospective and from a highly selected subgroup of patients. Limited retrospective data have also suggested a survival association with the resection of limited distant metastases. Given the complexity of these patients, multidisciplinary evaluation at a high-volume sarcoma center is critical.
Keyphrases
- end stage renal disease
- newly diagnosed
- chronic kidney disease
- ejection fraction
- electronic health record
- big data
- randomized controlled trial
- early stage
- machine learning
- radiation therapy
- cross sectional
- acute coronary syndrome
- clinical trial
- coronary artery disease
- radiation induced
- atrial fibrillation
- patient reported outcomes
- minimally invasive
- open label
- chemotherapy induced
- study protocol